PPIDT00421
Drug Information
| Name | Zolbetuximab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB15118 |
| Type | biotech |
| Indication | Zolbetuximab is indicated in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are claudin 18.2 positive as determined by an FDA-approved test.[L51923] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Intravenous |
20 mg/ml
|
| Injection, powder, for suspension | Intravenous |
20 mg/1mL
|